Center for Lawful Access and Abuse Deterrence 9/8/2014

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Center for Lawful Access and Abuse Deterrence 9/8/2014"

Transcription

1 ASPMN 24 th National Conference San Diego, CA September 17 20, 2014 Addressing an Evolving Epidemic Through Substance Use Intervention and Treatment Policies Michael C. Barnes Executive Director Conflict of Interest Disclosure The Center for Lawful Access and Abuse Deterrence (CLAAD) receives funding from businesses in the health care industry that share CLAAD s mission to reduce prescription drug fraud, diversion, misuse, and abuse while advancing consumer access to high quality health care. CLAAD s funders include pharmaceutical companies, treatment centers, and laboratories, and are disclosed on its website, CLAAD is managed by DCBA Law & Policy. DCBA also provides legal and policy counsel to professionals and businesses whose activities align with CLAAD s mission. To avoid conflicts of interest, DCBA adheres to the District of Columbia Rules of Professional Conduct Any views or opinions in this presentation are solely those of the author/presenter and do not necessarily represent the views or opinions of the American Society for Pain Management Nursing. Preview Introduction Responses to Opioid Abuse Trends in Substance Use Shifts in Supply Diminished Perceptions of Risk Affronts to Federal Authority More Therapeutic, Less Punitive Approach Crucial Role of Nurses Conclusion 1

2 Introduction Mission Lawful access: consumer access to high quality health care Moderation Abuse deterrence: preventing fraud, diversion, and abuse Information and analysis Policy leadership (governmental, corporate, professional) Coalition building (resource sharing and harmonization of efforts) Rx Abuse: Are We Making Progress? Federal Responses to Opioid Abuse Prosecutions and DEA enforcement (distributors, pharmacies) LA/ER opioid REMS (voluntary education) Secure and Responsible Drug Disposal Act Grant support (PMPs, research) Abuse deterrent opioids (federal legislation) New opioid labels ( severe enough ) Hydrocodone rescheduling recommendation 2

3 State Responses to Opioid Abuse Successful prosecutions Second degree murder (knowing indifference to consequence) Involuntary manslaughter (harmful activity w/o due caution) Mandatory PMP data checks Mandatory prescriber education all controlled substances Good Samaritan, naloxone laws first responders Pain clinic registration and regulation Safe prescribing and abuse prevention standards Corporate Responses to Opioid Abuse Pharmaceutical research and development Pain Addiction Testing for substance use Pharmacogenetic risk More definitive urine testing w/ greater sensitivity, specificity, accuracy and reliability (not yet implemented in sports) Locking devices Insurer data analysis and alerts Rx Abuse: Yes, We Are Making Progress Overdose deaths from opioids fall 27% in WA (1/28/14) Prescription drug deaths falling across FL (10/14/13) National survey shows reduced levels of Rx abuse among young adults (9/4/13) KY sees decline in drug overdose deaths, including Rx overdose (8/8/13) Opioid medication abuse down in 10 states (KY, LA, MA, MS, NH, NY, OH, OK, RI, WV) (1/8/13) Abuse deterrent medications can reduce the risk of diversion, misuse, and abuse (July 2012) 3

4 Shifting Supply Heroin use and buprenorphine misuse Decreasing supply of Rx medications available for abuse w/o corresponding demand reductions Raiding before regulating leads to denials of Rx medications for people with pain and SUDs Distributors, pharmacies MAT prescribers FedEx Greater availability of marijuana New substances of abuse Diminished Perceptions of Risk Alcohol: present in the household; a rite of passage Opioids, stimulants, and benzodiazepines: prescribed by a doctor, available at a pharmacy Marijuana: medicine and recreation ( safer than sugar ) Synthetics: available at malls, convenience stores, and online Analogs and counterfeits: same drug, slightly modified formulation, package, or language; available online E cigarettes: clean delivery of nicotine, THC, and opioids 3D printing: ordered online and printed at home Affronts to Federal Authority Ballot measures and legislation Importation of non FDA approved drugs Specific medication bans City and county level interference The Best of Both Worlds: Applying Federal Commerce and State Police Powers To Reduce Prescription Drug Abuse. MD. J. HEALTH CARE L. & POL Y (2013). 4

5 More Therapeutic, Less Punitive Approach ACA & Equity Act expand access to treatment Educate consumers Challenge insurance denials Acceptance of medication assisted treatment Drug courts reduce costs and recidivism Expansion of interventions and referrals to treatment Health care, education, employment, and criminal justice systems Non punitive testing for substance use Proposals for sentencing reform and voting rights restoration Crucial Role of Nurses Lead the implementation of best practices Watchdog and whistleblower Professional associations like ASPMN wield influence Break stereotypes and stigma Improve macro level policies and practices Touch every community and family Tremendous prevention and intervention resource Geographically dispersed Passion and credibility on issues Unified Call for Balance Jailing moms and seizing newborns in response to NAS Attacks on therapeutic testing for substance use Action against MAT practitioners Denials of care, turning away from treatment Barriers to medication assisted therapy Profiteering of dirty docs and liquid gold labs Prescription monitoring program data breaches 5

6 Policy Resources (since May 29, 2014) Blowing the Whistle on Dirty Docs Overdose Prevention Act (warm hand off) legislative proposal Letter of support for H.R (regulate before raiding) Safer Opioid Prescribing and Abuse Prevention Standards for Pain Management Principles for Urine Drug Testing in Addiction Medicine Practitioners May Not Profiteer from Drug Testing ACLU s Lawsuit Exemplifies Confusion Regarding Therapeutic Testing for Substance Use Law Review Articles Applying Lessons from the Opioid Abuse Epidemic to Protect Consumers from Gray Market Biologics, NOTRE DAME J.L. ETHICS & PUB. POL Y (Forthcoming 2014). Active Verification and Vigilance: A Method To Avoid Civil and Criminal Liability When Prescribing Controlled Substances, DEPAUL J. HEALTH CARE L. (2013). The Best of Both Worlds: Applying Federal Commerce and State Police Powers To Reduce Prescription Drug Abuse. MD. J. HEALTH CARE L. & POL Y (2013). Conclusion Thanks to Dr. Marsha Stanton and Pamela Bennett LinkedIn.com/in/michaelcbarnes CLAAD.org Thank You Questions and Discussion 6

Addressing an Evolving Epidemic Through Substance Use Intervention and Treatment Policies*

Addressing an Evolving Epidemic Through Substance Use Intervention and Treatment Policies* IntNSA 38 th Annual Educa3onal Conference Washington, DC October 16, 2014 Addressing an Evolving Epidemic Through Substance Use Intervention and Treatment Policies* Michael C. Barnes, Execu3ve Director,

More information

Proper Utilization of Urine Testing in Identifying and Treating Substance Use Disorders

Proper Utilization of Urine Testing in Identifying and Treating Substance Use Disorders CCSAD 27 th National Conference Hyannis, MA September 11 14, 2014 Proper Utilization of Urine Testing in Identifying and Treating Substance Use Disorders Michael C. Barnes Executive Director Conflict of

More information

National Perspectives in Medication Assisted Treatment

National Perspectives in Medication Assisted Treatment National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit

More information

Urine Drug Testing in Addiction Medicine

Urine Drug Testing in Addiction Medicine National Association of Alcohol and Drug Abuse Counselors (NAADAC) 2015 Annual Conference Bethesda, Maryland October 11, 2015 Urine Drug Testing in Addiction Medicine A Paradigm To Improve Outcomes and

More information

Reforming the Response To Substance Use: A Drug Policy for the 21 st Century

Reforming the Response To Substance Use: A Drug Policy for the 21 st Century Reforming the Response To Substance Use: A Drug Policy for the 21 st Century 2015 NASADAD MEETING Charleston, SC June 2, 2015 David Mineta, Deputy Director Office of Demand Reduction Office of National

More information

Governor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu

Governor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu Governor s Task Force on Mental Health and Substance Use www.ncdhhs.gov/mhsu Problem Statement 97 Painkiller prescriptions per 100 North Carolinians Number of deaths by drug overdose in North Carolina

More information

Substance Use: Addressing Addiction and Emerging Issues

Substance Use: Addressing Addiction and Emerging Issues MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population

More information

The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community

The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community November 2014 INTRODUCTION The Heroin

More information

SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources

SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services Administration 1 Overview National

More information

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

For a Healthier America: Reducing Prescription Drug Misuse and Abuse For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,

More information

The Current State of Drug Abuse Across the Nation. December 12, 2015

The Current State of Drug Abuse Across the Nation. December 12, 2015 The Current State of Drug Abuse Across the Nation December 12, 2015 Agenda The Partnership for Drug-Free Kids The macro picture Opioid abuse and addiction What can we do about it? Moving upstream: connecting

More information

December 2, 2014 EXECUTIVE SUMMARY. Table of Contents. I. Introduction... 2 II. Key Insights... 2

December 2, 2014 EXECUTIVE SUMMARY. Table of Contents. I. Introduction... 2 II. Key Insights... 2 December 2, 2014 EXECUTIVE SUMMARY Table of Contents I. Introduction... 2 II. Key Insights... 2 A. Access to Care... 2 1. Medications... 2 2. Interventions and Treatment for Substance Use... 2 B. Preserving

More information

Opioid Addiction & Corrections

Opioid Addiction & Corrections Opioid Addiction & Corrections Medication Assisted Treatment in the Connecticut Department of Correction April 30, 2015--CJPAC Kathleen F. Maurer, MD, MPH, MBA Medical Director and Director of Health and

More information

Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis

Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,

More information

U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health

U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health TESTIMONY of the American Medical Association before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health Re: Examining Legislative Proposals to Combat our Nation's

More information

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that

More information

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE WHAT WE KNOW The misuse and abuse of prescription drugs has become a leading cause of harm among New Hampshire adults,

More information

SPPAN Policy and Advocacy Priorities 2015

SPPAN Policy and Advocacy Priorities 2015 SPPAN S 2015 POLICY AND ADVOCACY PRIORITIES SPPAN surveyed its stakeholders to help identify the top policy priorities for 2015. Below, you will find our top policy issues for 2015 followed by information

More information

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices National Governors Association Policy Academy: Reducing Prescription Drug Abuse June 8, 2015 Burlington, VT Improving Interstate

More information

South Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives

South Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives South Dakota Prescription Drug Monitoring Program (SD PDMP) SD Academy of Physician Assistants Summer/Fall CME Conference September 6, 2012 Ron Huether, RPh, SD PDMP Kari Shanard Koenders, RPh, PDMP Director

More information

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse

More information

Traci C. Green, PhD, MSc Jody Rich, MD, MPH

Traci C. Green, PhD, MSc Jody Rich, MD, MPH Traci C. Green, PhD, MSc Jody Rich, MD, MPH Strategic Plan highlights Comments & Responses from public, stakeholders Input and discussion Next steps Death rate for U.S. non-hispanic whites (USW), U.S.

More information

Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA

Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA American Academy of Hospice and Palliative Care Medicine October,

More information

Methadone. Buprenorphine 10/9/2015

Methadone. Buprenorphine 10/9/2015 Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious

More information

Summit Spotlight Treatment Track breakout sessions announced

Summit Spotlight Treatment Track breakout sessions announced Volume 5, Issue 15, December 21, 2015 In This Issue: * Treatment Track breakout sessions announced 1. Drug overdose deaths reach all- time high 2. CDC releases draft opioid guidelines; seeks comments 3.

More information

OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E

OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E Sales of opioids: Michigan is above the median in

More information

King County Drug Trends 2015

King County Drug Trends 2015 Brad Finegood, MA, LMHC Assistant Division Director, Acting RSN Administrator Prevention and Treatment Coordinator King County Behavioral Health and Recovery Division Caleb Banta-Green PhD, MPH, MSW Senior

More information

5/31/2015. Statement of Need:

5/31/2015. Statement of Need: Statement of Need: The project was created in December 2012 to address the rapidly growing and increasingly devastating consequences of illicit opiate abuse in. The ultimate goal of the (HRI) is to create

More information

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who

More information

Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015

Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015 Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol New Mexico Pharmacists Association & Project ECHO 2014 This training fulfills the educational requirement for pharmacists in

More information

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org Disclosures Project Lazarus Zogenix Charitable Contribution 2015 Kaléo Charitable Contribution

More information

An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009

An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 Background Defining the problem: Opiates pain relievers (OxyContin,

More information

TESTIMONY. March 17, 2014. Rutland, VT

TESTIMONY. March 17, 2014. Rutland, VT Community Solutions to Breaking the Cycle of Heroin & Opioid Addiction TESTIMONY Harry Chen, MD, Commissioner of Health March 17, 2014 Senate Committee on the Judiciary Franklin Conference Center at the

More information

History of Prescription Drug Monitoring Programs. PDMP Training and Technical Assistance Center Brandeis University

History of Prescription Drug Monitoring Programs. PDMP Training and Technical Assistance Center Brandeis University History of Prescription Drug Monitoring Programs PDMP Training and Technical Assistance Center Brandeis University History of Prescription Drug Monitoring Programs First PDMP Early PDMP Characteristics

More information

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP

More information

PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES

PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES PART 3: PRESCRIBING OF CONTROLLED SUBSTANCES FOR NON-CANCER PAIN PREPARED BY THE

More information

Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD

Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem Thomas Kosten MD Waggoner Chair & Professor of Psychiatry & Neuroscience Baylor College of Medicine Past-President,

More information

THE PRESCRIPTION DRUG AND OPIATE ADDICTION EPIDEMIC IN SOUTHERN ILLINOIS

THE PRESCRIPTION DRUG AND OPIATE ADDICTION EPIDEMIC IN SOUTHERN ILLINOIS Community Behavioral Healthcare Association of Illinois Frank Anselmo, MPA Chief Executive Officer 3085 Stevenson Drive, Suite 203 Springfield, Illinois 62703 Phone: 217/585-1600 Fax: 217/585-1601 www.cbha.net

More information

State Substance Abuse Agencies and Prescription Drug Abuse Initial Results from a NASADAD Membership Inquiry

State Substance Abuse Agencies and Prescription Drug Abuse Initial Results from a NASADAD Membership Inquiry State Substance Abuse Agencies and Prescription Drug Abuse Initial Results from a NASADAD Membership Inquiry Cliff Bersamira, Research Analyst Rick Harwood, Research and Program Applications Director National

More information

A Drug Policy for the 21st Century

A Drug Policy for the 21st Century A Drug Policy for the 21st Century April 26, 2014 California Association for Alcohol and Drug Educators (CAADE) Conference Integrating Mental Health and Substance Use Disorder Services David K. Mineta,

More information

Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture

Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational

More information

Opioid overdose can occur when a patient misunderstands the directions

Opioid overdose can occur when a patient misunderstands the directions Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription

More information

2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov

2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion

More information

Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014

Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014 Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014 Denise Paone and Alexandra Harocopos Bureau of Alcohol & Drug Use Prevention, Care & Treatment New York City Department

More information

Drug Abuse Trends in the Seattle/King County Area: 2013

Drug Abuse Trends in the Seattle/King County Area: 2013 Drug Abuse Trends in the Seattle/King County Area: 2013 Caleb Banta-Green 1, T. Ron Jackson 2, Steve Freng 3, Michael Hanrahan 4, Cynthia Graff 5, John Ohta 6, Mary Taylor 7, Richard Harruff 8, Robyn Smith

More information

Washington State Interagency Opioid Working Plan

Washington State Interagency Opioid Working Plan Washington State Interagency Opioid Working Plan INTRODUCTION January 2016 Washington State is currently experiencing an opioid abuse and overdose crisis involving prescription opioids and heroin. Approximately

More information

Substance Abuse Treatment Admissions for Abuse of Benzodiazepines

Substance Abuse Treatment Admissions for Abuse of Benzodiazepines Treatment Episode Data Set The TEDS Report June 2, 2011 Substance Abuse Treatment Admissions for Abuse of Benzodiazepines Benzodiazepines are a class of central nervous system depressant drugs that are

More information

Federal Response to Opioid Abuse Epidemic

Federal Response to Opioid Abuse Epidemic Healthcare Committee Federal Response to Opioid Abuse Epidemic On May 1, 20215 the Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled What is the Federal Government

More information

The Prescription Drug Abuse and Heroin Crisis: New York s Response

The Prescription Drug Abuse and Heroin Crisis: New York s Response The Prescription Drug Abuse and Heroin Crisis: New York s Response Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 The Connection States with more opioid

More information

Opioids and the Injured Worker Tools for Successful Outcomes

Opioids and the Injured Worker Tools for Successful Outcomes Opioids and the Injured Worker Tools for Successful Outcomes Tim Pokorney, RPh Director, Clinical Express Scripts Workers' Compensation Division Goals and Objectives Alarming statistics for narcotic utilization,

More information

Preventing Fatal Opioid Overdose Among Injection Drug Users. Skye Tikkanen Connections Counseling Scott Stokes AIDS Resource Center of Wisconsin

Preventing Fatal Opioid Overdose Among Injection Drug Users. Skye Tikkanen Connections Counseling Scott Stokes AIDS Resource Center of Wisconsin Preventing Fatal Opioid Overdose Among Injection Drug Users Skye Tikkanen Connections Counseling Scott Stokes AIDS Resource Center of Wisconsin I have no relevant financial interests to disclose for this

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

Drug Abuse Trends in the Seattle-King County Area: 2014

Drug Abuse Trends in the Seattle-King County Area: 2014 Drug Abuse Trends in the Seattle-King County Area: 2014 June 12, 2015 Caleb Banta-Green 1, T. Ron Jackson 2, Steve Freng 3, Michael Hanrahan 4, Cynthia Graff 5, John Ohta 6, Mary Taylor 7, Richard Harruff

More information

Marijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century

Marijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century Mother s little helper: Prescription drug abuse in the 21 st century Carol Falkowski CEO and Founder Drug Abuse Dialogues St. Paul, Minnesota www.drugabusedialogues.com More kids smoke marijuana than smoke

More information

A Drug Policy for the 21st Century. Office of National Drug Control Policy

A Drug Policy for the 21st Century. Office of National Drug Control Policy A Drug Policy for the 21st Century October 18, 2014 International Nurses Society on Addictions Health Care Reform & Its Impact on Addictions Nursing: Navigating Change through the Rapids David K. Mineta,

More information

A New Generation of Prescription Monitoring Programs: Best & Promising Practices

A New Generation of Prescription Monitoring Programs: Best & Promising Practices A New Generation of Prescription Monitoring Programs: Best & Promising Practices National PDMP Meeting Washington, DC September 25, 2013 Presented by John L Eadie Why Is a New Generation of PDMPs Being

More information

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State ADAI-IB 23-3 INFO Brief Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State O ctober 23 Caleb Banta-Green (Alcohol and Drug Abuse Institute, University of Washington),

More information

Recommendations of the Governor s Task Force on Prescription Drug and Heroin Abuse

Recommendations of the Governor s Task Force on Prescription Drug and Heroin Abuse Recommendations of the Governor s Task Force on Prescription Drug and Heroin Abuse Jodi Manz, MSW Policy Advisor Office of the Secretary of Health and Human Resources October 7, 2015 Rates of of Opioid

More information

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,

More information

Prescription Monitoring Programs: Creating a National Network

Prescription Monitoring Programs: Creating a National Network Prescription Monitoring Programs: Creating a National Network Danna E. Droz, JD, RPH PMP Liaison ddroz@nabp.net 847/391-4508 United States Drug Enforcement Administration National Conference on Pharmaceutical

More information

Testimony of The New York City Department of Health and Mental Hygiene. before the

Testimony of The New York City Department of Health and Mental Hygiene. before the Testimony of The New York City Department of Health and Mental Hygiene before the New York City State Assembly Committee on Alcoholism and Drug Abuse on Programs and Services for the Treatment of Opioid

More information

Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008

Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008 Treatment Episode Data Set The TEDS Report July 15, 010 Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 008 In Brief The proportion of all substance abuse treatment admissions

More information

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,

More information

Statement. of the. American Medical Association. to the

Statement. of the. American Medical Association. to the Statement of the American Medical Association to the Committee on Energy & Commerce Subcommittee on Oversight and Investigations United States House of Representatives Re: Combatting the Opioid Abuse Epidemic:

More information

ARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E

ARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use

More information

Pharmacy Law Overview. From Civil Liability to Criminal Prosecution

Pharmacy Law Overview. From Civil Liability to Criminal Prosecution Pharmacy Law Overview From Civil Liability to Criminal Prosecution Law That Matters To Pharmacists Robert P. Esgro, R.Ph., Esq. Pharmacy Lawyer and Consultant 610-308-6666 Bob@PharmacyLawyer.com Pharmacy

More information

2.1 Staying Clear of the Law and Addiction: Nevada s Pre- Criminal Intervention Program

2.1 Staying Clear of the Law and Addiction: Nevada s Pre- Criminal Intervention Program PMP Center of Excellence Notes from the Field 2.1 Staying Clear of the Law and Addiction: Nevada s Pre- Criminal Intervention Program January 2011 This project was supported by Grant No. 2006-DG-BX-K071

More information

A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death

A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death 2013 WPHA-WALHDAB Annual Conference Wednesday, May 22: 2:00-2:35 pm Lisa Bullard-Cawthorne, MS, MPH OPIATE PREVALENCE IN DANE

More information

Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion

Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures

More information

Lazarus Recovery Services

Lazarus Recovery Services Lazarus Recovery Services Overdose Survivors Group Family Addiction Support Family Peer Specialist Support Housing Family Overdose Support Biological Psychological Parent/ Family Empowerment Faith Individual

More information

NATIONAL PRESCRIPTION DRUG ABUSE PREVENTION STRATEGY

NATIONAL PRESCRIPTION DRUG ABUSE PREVENTION STRATEGY NATIONAL PRESCRIPTION DRUG ABUSE PREVENTION STRATEGY 2015 UPDATE Addressing the Evolution of the Epidemic About CLAAD The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) coordinates

More information

QUEEN ANNE S COUNTY STRATEGIC PLAN ALCOHOL AND DRUG ABUSE SERVICES

QUEEN ANNE S COUNTY STRATEGIC PLAN ALCOHOL AND DRUG ABUSE SERVICES QUEEN ANNE S COUNTY STRATEGIC PLAN ALCOHOL AND DRUG ABUSE SERVICES 2016 2018 INTRODUCTION Local councils are established under Chapters 237 and 238 of the Acts of the General Assembly of Maryland of 2004,

More information

Center for Lawful Access and Abuse Deterrence

Center for Lawful Access and Abuse Deterrence August 8, 2014 Karen Perry Executive Director NOPE Task Force 3223 Commerce PL West Palm Beach, FL 33407 Re: Overdose Death Prevention Act Dear Karen: Thank you for your April email regarding Florida s

More information

Iowa Governor s Office of Drug Control Policy

Iowa Governor s Office of Drug Control Policy Iowa Governor s Office of Drug Control Policy medicines or take them in a manner not prescribed, we increase the risk of negative effects. It is estimated that over 35 million Americans are ages 65 and

More information

Populations at risk for opioid overdose

Populations at risk for opioid overdose Populations at risk for opioid overdose Len Paulozzi, MD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention April

More information

Web-Based Resources. Locating Treatment

Web-Based Resources. Locating Treatment Web-Based Resources Locating Treatment http://dpt2.samhsa.gov/treatment/ -- This is the Substance Abuse and Mental Health Services Administration s (SAMHSA) page for locating both public and private opiate

More information

Affordable Care Act: Health Coverage for Criminal Justice Populations. Colorado Center on Law and Policy Colorado Criminal Justice Reform Coalition

Affordable Care Act: Health Coverage for Criminal Justice Populations. Colorado Center on Law and Policy Colorado Criminal Justice Reform Coalition Affordable Care Act: Health Coverage for Criminal Justice Populations Colorado Center on Law and Policy Colorado Criminal Justice Reform Coalition Who we are CCJRC and CCLP have partnered to help Colorado

More information

What is an opioid? Why address opioid use in your county? Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose

What is an opioid? Why address opioid use in your county? Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose What is an opioid? Opioids are a type of pain-relief medication. According to the National Institute on Drug

More information

Rx and Heroin Abuse :Taking Action

Rx and Heroin Abuse :Taking Action Rx and Heroin Abuse :Taking Action Dan Hicks, Manager, Prevention Services November 21, 2014 Page 1 Rx Abuse & Heroin: Increasing Awareness Young people are abusing prescription drugs at alarming rates.

More information

Naloxone Distribution for Opioid Overdose Prevention

Naloxone Distribution for Opioid Overdose Prevention Naloxone Distribution for Opioid Overdose Prevention Caleb Banta-Green PhD, MPH, MSW Alcohol and Drug Abuse Institute, University of Washington Alan Melnick, MD, MPH Clark County Public Health Chris Humberson,

More information

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse

More information

RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING

RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING [R23-1-OPOIDR] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH April 2014 (E) COMPILER S NOTES: Proposed Additions: The

More information

Summit Spotlight Summit changes name to reflect growing heroin epidemic across United States

Summit Spotlight Summit changes name to reflect growing heroin epidemic across United States Volume 5, Issue 9, October 29, 2015 In This Issue: * Summit changes name to include heroin focus * Three days left to save $300 on registration 1. Teens prescribed opioids more likely to abuse as adults

More information

Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS)

Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) Initial REMS approval: 02/2013 Most recent modification: 06/2015 Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) This REMS applies

More information

Presentation by: Commissioner E. Douglas Varney

Presentation by: Commissioner E. Douglas Varney Presentation by: Commissioner E. Douglas Varney Prescription Drug Abuse Affects Everyone Families as a whole Women Children The abuse of prescription drugs, particularly opioids, is costly not only for

More information

Testimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition

Testimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition Testimony on Opioid Overdose Prevention Daniel Raymond, Policy Director, Harm Reduction Coalition Presented on March 25, 2014 to the House Appropriations Subcommittee on Labor, Health and Human Services,

More information

Community Response to Heroin and Opiate Usage in Northern Rice County

Community Response to Heroin and Opiate Usage in Northern Rice County Community Response to Heroin and Opiate Usage in Northern Rice County Minnesota Rural Health Conference June 28 th and 29 th 2010 Presented By Kathleen Meier Andrew Yurek Northfield Hospital and Clinics

More information

Summit Spotlight Save $300 off Rx Summit rates through Oct. 31

Summit Spotlight Save $300 off Rx Summit rates through Oct. 31 Volume 5, Issue 8, October 22, 2015 In This Issue: * Save $300 off Rx Summit rates through October 31 * SAM Education Summit registration available 1. The CDC's promising plan to curb opioid dependence

More information

Outline. Interventions to Reduce Opioid Overdose State of the Art 9/23/2013

Outline. Interventions to Reduce Opioid Overdose State of the Art 9/23/2013 Interventions to Reduce Opioid Overdose State of the Art Caleb J. Banta Green PhD MPH MSW Research Scientist Alcohol and Drug Abuse Institute Affiliate Asst. Professor School of Public Health University

More information

Licensure of Substance Abuse Treatment Programs Required Amendments

Licensure of Substance Abuse Treatment Programs Required Amendments Licensure of Substance Abuse Treatment Programs Required Amendments Public Health Council August 12, 2015 Jim Cremer, Deputy Director Erica Piedade, Director of Quality Assurance & Licensing, Overview

More information

P U B L I C H E A L T H A D V I S O R Y

P U B L I C H E A L T H A D V I S O R Y The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619Tel: 617-624-6000 Fax: 617-624-5206 www.mass.gov/dph

More information

John R. Kasich, Governor Orman Hall, Director

John R. Kasich, Governor Orman Hall, Director John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic

More information

OREGON DRUG CONTROL UPDATE. Drug Use Trends in Oregon

OREGON DRUG CONTROL UPDATE. Drug Use Trends in Oregon OREGON DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Oregon. Oregon At-a-Glance: In 2009-2010, Oregon was one of the top ten states

More information

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,

More information

NYC RxStat: A Collaborative Approach to Surveillance of Prescription Drug Misuse and Associated Consequences

NYC RxStat: A Collaborative Approach to Surveillance of Prescription Drug Misuse and Associated Consequences NYC RxStat: A Collaborative Approach to Surveillance of Prescription Drug Misuse and Associated Consequences National Governor s Association Institute for Governors Criminal Justice Policy Advisors Washington,

More information

Nurse Practitioners' Role in Preparing Community Members for Opioid-Associated Overdose Rescue:

Nurse Practitioners' Role in Preparing Community Members for Opioid-Associated Overdose Rescue: Nurse Practitioners' Role in Preparing Community Members for Opioid-Associated Overdose Rescue: Using a Computer-Based Module to Train Laypersons and Advocating for Naloxone Legislation International Nurses

More information

Opioid/Opiate Dependent Pregnant Women

Opioid/Opiate Dependent Pregnant Women Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than

More information

Opioid Treatment Programs at the Baltimore City Detention Center

Opioid Treatment Programs at the Baltimore City Detention Center Opioid Treatment Programs at the Baltimore City Detention Center Greg Warren, MA, MBA Director of Substance Abuse Services Maryland Department of Public Safety and Correctional Services OTP Interventions

More information

Emerging Issues in Workers Compensation: Medical Marijuana

Emerging Issues in Workers Compensation: Medical Marijuana Emerging Issues in Workers Compensation: Medical Marijuana Lori Lovgren Division Executive State Relations Federal Law on Marijuana On a federal level, it s illegal to possess marijuana for any reason;

More information

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS 2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS Research current through September 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy.

More information